Dr. Hao Sun 孙浩
Chief Physician
Gastrointestinal Tumor Center, Chongqing University Cancer Hospital, Chongqing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radical surgery for gastric, colon, and rectal cancer; postoperative adjuvant chemotherapy; tumor targeted therapy; and biological therapy.
Dr. Sun holds a Master of Medicine from Chongqing Medical University and serves as a master’s supervisor at Guangxi Medical University. With experience in general surgery clinical teaching and basic research, Dr. Sun has published nearly 20 papers and co-edited national textbooks on oncology. Dr. Sun led two municipal research projects and received the Third Prize for Chongqing Science and Technology Progress.
Professional roles
- Member, Medical Malpractice Technical Appraisal Expert Pool, Yuzhong District Medical Association, Chongqing
- Member, Colorectal Cancer Expert Group, Chongqing University Cancer Hospital
Name order: in Chinese the family name comes first (Sun Hao). Papers usually list the name as Hao Sun or Sun H.
Selected publications
46 papers on PubMed matched by name and affiliation; 30 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancers (Basel), 2026 (senior author): Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis. PubMed 42352549
- Front Oncol, 2026 (senior author): Case Report: Integration of intratumoral oncolytic adenovirus with total neoadjuvant therapy in metachronous locally advanced rectal cancer. PubMed 42022327
- BMC Cancer, 2026 (senior author): Clinical significance of the pretreatment C-reactive protein-albumin-lymphocyte (CALLY) index in colorectal cancer patients: a meta-analysis. PubMed 41530698
- Hepatology, 2026 (senior author): Letter to the Editor: Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content-Systematic review and network meta-analysis. PubMed 40053862
- Syst Rev, 2025 (senior author): Prognostic value of the pretreatment Naples prognostic score in gastrointestinal cancer patients: an updated meta-analysis with 28 studies. PubMed 41074216
- Hepatology, 2025 (senior author): Letter to the Editor: Fiber and whole grain intakes in relation to liver cancer risk-An analysis in 2 prospective cohorts and systematic review and meta-analysis of prospective studies. PubMed 40080834
- JAMA, 2025 (senior author): Negative Pressure Dressings to Prevent Surgical Site Infection. PubMed 40455463
- Precis Clin Med, 2025 (senior author): Dual anti-HER2 therapy combined with chemotherapy as a novel neoadjuvant treatment option for locally advanced HER2-positive and microsatellite stable colon cancer. PubMed 39790478
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion